Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Departmental review of surgical cases during the past 17 years: Esophageal cancers].
Oga T, Saeki K, Eto A, Hashimoto K, Kimura K, Ito S, Niki M, Nozoe T, Watanabe M, Morita M, Kitamura K, Shiroto Y, Tsutsui S, Nakajima H, Ono M, Fujiya S, Matsuda H, Maekawa S, Kitamura M, Mori M, Matsuura H, Kuwano H, Kai H, Kamio H, Okudaira T. Oga T, et al. Among authors: morita m. Fukuoka Igaku Zasshi. 2002 Mar;93(3 Suppl):4-8. Fukuoka Igaku Zasshi. 2002. PMID: 11989241 Review. Japanese. No abstract available.
Trastuzumab and breast cancer: developments and current status.
Tokunaga E, Oki E, Nishida K, Koga T, Egashira A, Morita M, Kakeji Y, Maehara Y. Tokunaga E, et al. Among authors: morita m. Int J Clin Oncol. 2006 Jun;11(3):199-208. doi: 10.1007/s10147-006-0575-4. Int J Clin Oncol. 2006. PMID: 16850126 Review.
[A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
Oki E, Kakeji Y, Yoshida R, Ikeda K, Nishida K, Koga T, Egashira A, Tokunaga E, Morita M, Baba H, Maehara Y. Oki E, et al. Among authors: morita m. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:138-43. Gan To Kagaku Ryoho. 2006. PMID: 16897990 Clinical Trial. Japanese.
Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
Tokunaga E, Oki E, Kimura Y, Yamanaka T, Egashira A, Nishida K, Koga T, Morita M, Kakeji Y, Maehara Y. Tokunaga E, et al. Among authors: morita m. Breast Cancer Res Treat. 2007 Mar;101(3):249-57. doi: 10.1007/s10549-006-9295-8. Epub 2006 Sep 28. Breast Cancer Res Treat. 2007. PMID: 17006756
3,519 results